lifestyle.thepointnews.com

Author: Nxera Pharma

Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

February 12, 2026
Nxera Pharma Webinar Presentation for FY2025 Financial Results

January 26, 2026
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders

January 20, 2026
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

January 19, 2026